Int J Biol Sci 2022; 18(14):5309-5311. doi:10.7150/ijbs.75891 This issue Cite

Erratum

Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum

Deng-Pan Wu1,2*, Yan Zhou4*, Li-Xiang Hou1*, Xiao-Xiao Zhu1, Wen Yi1, Si-Man Yang3, Tian-Yu Lin1, Jin-Lan Huang1,2, Bei Zhang5, Xiao-Xing Yin1✉

1. Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Pharmacy School of Xuzhou Medical University, Xuzhou City, Jiangsu Province, 221004, P.R. China.
2. Department of Pharmacology, Pharmacy School of Xuzhou Medical University, 221004, Xuzhou City, Jiangsu Province, P.R. China.
3. Scientific research center of traditional Chinese medicine, Guangxi University of Chinese Medicine, Nanning City, Guangxi Zhuang Autonomous Region, P.R. China.
4. Clinical Pharmacy, Jingjiang People's Hospital, 214500, Jingjiang City, Jiangsu Province, P.R. China.
5. Department of gynaecology and obstetrics, Xuzhou Central Hospital, 221009, Xuzhou City, Jiangsu Province, P.R. China.
*These authors contributed equally to this work.

Citation:
Wu DP, Zhou Y, Hou LX, Zhu XX, Yi W, Yang SM, Lin TY, Huang JL, Zhang B, Yin XX. Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum. Int J Biol Sci 2022; 18(14):5309-5311. doi:10.7150/ijbs.75891. https://www.ijbs.com/v18p5309.htm
Other styles

File import instruction

Corrected-article in Int J Biol Sci, Volume 17, 2380


Citation styles

APA
Wu, D.P., Zhou, Y., Hou, L.X., Zhu, X.X., Yi, W., Yang, S.M., Lin, T.Y., Huang, J.L., Zhang, B., Yin, X.X. (2022). Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum. International Journal of Biological Sciences, 18(14), 5309-5311. https://doi.org/10.7150/ijbs.75891.

ACS
Wu, D.P.; Zhou, Y.; Hou, L.X.; Zhu, X.X.; Yi, W.; Yang, S.M.; Lin, T.Y.; Huang, J.L.; Zhang, B.; Yin, X.X. Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum. Int. J. Biol. Sci. 2022, 18 (14), 5309-5311. DOI: 10.7150/ijbs.75891.

NLM
Wu DP, Zhou Y, Hou LX, Zhu XX, Yi W, Yang SM, Lin TY, Huang JL, Zhang B, Yin XX. Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum. Int J Biol Sci 2022; 18(14):5309-5311. doi:10.7150/ijbs.75891. https://www.ijbs.com/v18p5309.htm

CSE
Wu DP, Zhou Y, Hou LX, Zhu XX, Yi W, Yang SM, Lin TY, Huang JL, Zhang B, Yin XX. 2022. Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum. Int J Biol Sci. 18(14):5309-5311.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image